The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk

Fiji: an open-source platform for biological-image analysis

Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 67.6K citations · Full text

Biology, Biological-image Analysis, Image Analysis +8

Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

Alan S. Go, Glenn M. Chertow, Dongjie Fan et al. · New England Journal of Medicine · 2004 · 11.2K citations · Full text

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Daniel Levy, Robert J. Garrison, Daniel D. Savage et al. · New England Journal of Medicine · 1990 · 5.7K citations · Full text

FGF23 induces left ventricular hypertrophy

Christian Faul, Ansel P. Amaral, Behzad N. Oskouei et al. · Journal of Clinical Investigation · 2011 · 2K citations

Hypertension, Heart Failure, Pathology +18

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

Tamara Isakova · Kidney International · 2011 · 1.2K citations · Full text

Renal Function, Medicine, Physiology +9